Atlas Trials

A Study of 9MW2821 Versus Chemotherapy in Participants With Previously Treated Locally Advanced or Metastatic Triple-Negative Breast Cancer

Clinical trial NCT07556848 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07556848
Sponsor
Mabwell (Shanghai) Bioscience Co., Ltd.
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Locally Advanced or Metastatic Triple-negative Breast Cancer
Start date
2026-05-01
Primary completion
2027-12-01
Enrollment
356

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.